Filters
A single dose of dexamethasone during nonurgent, noncardiac surgery does not increase the risk of surgical-site infection (SSI), according to results of the PADDI* trial.
New drug applications approved by US FDA as of 16-30 June 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
